COGSTATE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.4 AUD | +2.19% |
|
+5.66% | -3.11% |
| Apr. 01 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
| Feb. 22 | Cogstate's Fiscal H1 Attributable Profit Jumps, Revenue Rises 3%; Shares Decline 8% | MT |
Evolution of the average Target Price on Cogstate Limited
Price target over the last 5 years
History of analyst recommendation changes
d42b1.5NECjs9ydQLe-1lc2YwDvBaskp5X30TbhjwCuivhCaM.kKJSzKAwH0a2vxQzt_tB63fKpPtmu3SsyVN293rYesaOgEjRmUcMdoeIKg~2a127c5df1ad85b5867cf2ba7d293941
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.4
AUD
Average target price
1.8
AUD
Spread / Average Target
+28.57%
High Price Target
1.8
AUD
Spread / Highest target
+28.57%
Low Price Target
1.8
AUD
Spread / Lowest Target
+28.57%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CGS Stock
- Consensus Cogstate Limited
